Jade,
Since the product is reusable, your CMC program should incorporate appropriate aspects to the evaluation and performance of the combination including reliability, robustness and repeatability of the combination to perform under ICH, stability, through life, through use, mis-use, etc. You should also consider human factors testing to support the re-use of the combination.
You haven't indicated if the combination's primary mode of action is that of the drug or device so it is difficult to know who the primary review division will be but since it is packaged in the medical device and will be "re-used" then there are other CMC considerations that should be identified and incorporated into your CMC program.
All the best,
Dar
-------------------------------------------
Darlene Rosario
Principal Consultant RA, Quality and Compliance
Velocity Consulting
Ventura CA
United States
-------------------------------------------
Original Message:
Sent: 04-08-2014 21:40
From: Jade Tian
Subject: drug-device combo, reusable vs. single use
Hello everyone,
Are there differences in CMC regulatory considerations when the drug-device combo is single use vs. reusable? This is when the pre-assembled medical device is the primary packaging.
Jade